ReviewFrontiers in neurology2025
Hyperglycemic effects on limbs tingling and twisting sensations.
Review in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What Hyperglycemia Does to the Legs is quite devastating and ends with the tragic event of losing lower limbs. A patient with diabetic neuropathy (DN) may have both good and sensory loss. On one hand, there are symptoms like pain, sensitivity, tingling, cramping, and cold feet. On the other hand, there are negative symptoms, including sensory loss and delayed wound healing the cues back up this negative out comes (Sensory nerves are essential for healing wounds because they help regulate the immune system and encourage the movement of cells, the creation of growth factors, and the reproduction of cells). When sensory nerves are injured or cut off, there is a decline in neuropeptides and white blood cell presence, which slows down the healing process. This problem is especially seen in diabetic neuropathy, as the loss of sensory functions greatly affects the ability to heal wounds, Chronic wounds display high levels of inflammation, reduced activity of growth factors, and poor oxygen supply to tissues, which all lead to slow healing and the persistence of non-healing wounds. The development and progression of DN cannot be explained solely by elevated blood glucose levels. New evidence suggests that a naturally occurring reactive metabolite called MG (methylglyoxal) can enhance function by modifying neuronal ion channels involved in chemo sensing and action potential generation in nociceptive nerve endings. This modification occurs after Glo1 (glyoxalase I) levels are reduced. One possible reason for the development of DN is the effect of dicarbonyls on the neuronal compartment. Thus, there may be new and improved ways to treat DN if we focus on preventing the buildup and effects of MG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.